A medical worker holds an ampule "component 1" of the two-component Gam-COVID-VAK (trademark "Sputnik V") coronavirus vaccine before vaccination, in Moscow, Russia. On December 26 Russia approved the main COVID-19 vaccine, Sputnik V, for use by people over the age of 60.